In the shadow of the financial crisis pharmaceutical companies are considering outsourcing functions to service providers that specialize in non-core functions. Successful outsourcing allows a company to focus more on the performance of product development and to delegate other operations to one or more service providers who can reduce costs and improve performance in these non-core functions. However, the greatest challenge to get the improvements and cost reductions is the way the outsourcing is performed.
Rechon Life Science offers services within the entire pharmaceutical development process, from phase II development through validation, manufacturing, packaging and labeling.
“There is an increasing need for the pharma industry to become more time and cost effective, and we can speed up the entire process, from the first contact and the idea stage to contract manufacturing,” says Anders Ulfhielm, Executive Vice President, Business Development for Rechon Life Science.
To get a win-win situation for all involved parties the following three critical success factors are essential
An outsourcing contract can facilitate communications management by creating procedures for exchanging information and communicating issues first within the internal organizational structure of the outsourcing service provider and the customer and then between the parties.
“With the Rechon project management tools we secure a fast and efficient reliable communication between the parties. Being located in the south of
The greatest performance management challenge is to clarify the scope and define the critical functions that are delivering customer’s success of the outsourced functions. After identifying these critical functions performance measurement must be put in place.
Rechon Life Science has a very interesting platform both for the developing and manufacturing of pharmaceuticals. Offering excellent conditions in terms of experienced staff and state-of-the-art technology, the company aims to help clients speed up their processes and reach patients faster.
It’s also important to think “out-of-the-box”. Because Rechon Life Science is owned by a Chinese company other added values could be part of collaboration. “Being part of a global Chinese cooperation has several advantages, for example we can provide our customers with an established manufacturing in
Both parties need to share cost reliability. The customer enters into a contract based on the savings, while we as a service provider perform services to create our profit margin.
An outsourcing contract needs to include a structured change management procedure with routines for additional services that justify additional fees. Procedures to address new or additional services to customer personnel must be clearly approved. If not, it creates conflicts. “To secure this we also have a quotation and agreement procedure including an efficient project management” says Anders Ulfhielm. “This help clients to speed up their market entry at a lower cost.”
“We want to be a reliable partner to companies throughout their entire process of drug development, not just deliver a naked vial. With passion and professionalism we want to improve quality of life.”